Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats
Language English Country United States Media print
Document type Journal Article
PubMed
20618395
DOI
10.1111/j.1528-1167.2010.02604.x
PII: EPI2604
Knihovny.cz E-resources
- MeSH
- Anticonvulsants pharmacology MeSH
- Anti-Anxiety Agents pharmacology MeSH
- Electric Stimulation MeSH
- Epilepsy chemically induced drug therapy MeSH
- Indans pharmacology therapeutic use MeSH
- Rats MeSH
- Psychomotor Performance drug effects MeSH
- Pyridines pharmacology therapeutic use MeSH
- Receptors, Metabotropic Glutamate antagonists & inhibitors MeSH
- Thiazoles pharmacology therapeutic use MeSH
- Age Factors MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- 1-aminoindan-1,5-dicarboxylic acid MeSH Browser
- 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine MeSH Browser
- 6-methyl-2-(phenylethynyl)pyridine MeSH Browser
- Anticonvulsants MeSH
- Anti-Anxiety Agents MeSH
- Indans MeSH
- Pyridines MeSH
- Receptors, Metabotropic Glutamate MeSH
- Thiazoles MeSH
Antagonists of group I of metabotropic glutamate receptors (mGluRs) exhibit anticonvulsant as well as anxiolytic action in adult rodents. Therefore, we started to study these effects in developing rats. Motor seizures induced by pentylenetetrazol (PTZ) and cortical epileptic afterdischarges (CxADs) elicited by electrical stimulation were used in immature rats. High doses of antagonists were needed to demonstrate anticonvulsant effects. Antagonist of mGluR1 AIDA [(R,S)-1-aminoindan-1,5-dicarboxylic acid] suppressed the tonic phase of PTZ-induced generalized tonic-clonic seizures in 7-, 12-, and 18-day-old rats, but not in 25-day-old rats. No significant effect of AIDA against CxADs was found. Antagonists of mGluR5-MPEP [2-methyl-6-(phenylethynyl)-pyridine] and MTEP [3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine] exhibited the same effect against PTZ-induced seizures as AIDA. In addition, they exhibited an anticonvulsant action against CxADs in 12- and 18-day-old rats. No drug compromised motor performance. Anxiolytic action of all three antagonists was demonstrated in light/dark box or in elevated plus maze tests. Homing reaction was used as an age-appropriate test of learning. AIDA did not affect homing, whereas the highest dose of MPEP compromised this behavior in 12- and partially in 18-day-old rats. The three antagonists possess age-dependent anticonvulsant as well as anxiolytic action, with minimal negative side effects.
References provided by Crossref.org